Entrepreneur and Pharmaceutical Industry Innovator
- Sobey Executive MBA 2011
- Winner of a Sobey EMBA Alumni 25th Anniversary Impact Award
Greg Patey is a co-founder of STI Technologies Limited, an award-winning company that made its mark streamlining the process of disseminating pharmaceutical samples. Although details have not been made public, local media reported the recent high-value sale of STI to QuintilesIMS, a global healthcare giant with branches in more than 100 countries.
Prior to attending Saint Mary’s University, Mr. Patey was educated at Memorial University of Newfoundland and worked in sales and marketing in the pharmaceutical industry while at the same time branching out as the owner and operator of two optical retail outlets in Mount Pearl, Newfoundland. His career took a sharp turn in 2001 when he co-founded and developed a startup that invented a new technology to address concerns about medication samples. Not only did this technology enhance regulatory practices, it also contributed to environmental sustainability and cost-savings by decreasing the amount of packaging materials required and the number of samples discarded. The original technological idea has evolved into many uses by the pharmaceutical industry over a 15-year span.
Patey and STI Technologies have received numerous nominations and awards over the years, including the Ernest C. Manning Innovation Award, the Ernst and Young Entrepreneur of the Year Award nominees (Atlantic) for Innovation, and Atlantic Canada Progress awards for Fastest Growing Companies, Top 101 Growing Companies, and Best Places to Work. Deloitte has also recognized STI with awards for Canada’s Best Managed Companies, Canada’s Technology Fast 50, and North America’s Technology Fast 500.
A lifelong learner, Mr. Patey completed his EMBA at the Sobey School of Business in 2011 and soon after leaped into work on a Doctor of Business Administration (DBA) at the University of Liverpool in the UK. We look forward to congratulating him on the completion of his thesis in early 2018.